The Asia Pacific Medical Tricorder Market would witness market growth of 10.0% CAGR during the forecast period (2023-2030).
The primary function of medical tricorders is diagnostics. These devices can quickly and accurately identify various medical conditions, including infectious diseases, cardiovascular issues, respiratory problems, etc. They can provide initial assessments and triage in emergencies, saving crucial time in critical care. Medical tricorders are instrumental in managing chronic diseases like diabetes, hypertension, and chronic obstructive pulmonary disease (COPD). Patients can monitor their conditions and receive timely alerts and recommendations.
Furthermore, tricorders are valuable tools for monitoring maternal health during pregnancy and ensuring the well-being of newborns. They can detect conditions such as pre-eclampsia and monitor vital signs in infants. These devices are ideal for point-of-care testing, allowing healthcare providers to perform on-the-spot diagnostics and make immediate treatment decisions, especially in resource-limited settings. Beyond medical conditions, medical tricorders support health and wellness initiatives. They can provide information on fitness, nutrition, and lifestyle choices to promote healthier living.
As per the data from the Indian Brand Equity Foundation, by 2030, India’s medical equipment sector is expected to be worth US$50 billion. Over time, this industry has drawn large investments. Foreign investments in medical devices reached Rs. 2,196 crore (US$ 301.01 million) in FY20, a 98% YoY growth. Demand will be increased by government programs like the "Production Linked Incentive (PLI) Scheme for Medical Devices 2020" and the creation of medical parks. The rising medical devices segment in countries like China and India can boost the demand for medical tricorders in Asia.
The China market dominated the Asia Pacific Medical Tricorder Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $607.6 million by 2030. The Japan market is exhibiting a CAGR of 9.3% during (2023 - 2030). Additionally, The India market would experience a CAGR of 10.7% during (2023 - 2030).
Based on Application, the market is segmented into Diagnosis, Monitoring and Others. Based on Type, the market is segmented into Wireless, USB Camera, Fiber Optic Camera, Corded and Others. Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Healthy.io Ltd., Ionis Pharmaceuticals, Inc., Fujikura Ltd., Basler AG, Qualcomm, Inc., Hamamatsu Photonics K.K., Basil Leaf Technologies, DynoSense Corp, Cloud DX Inc., and QuantuMDx Group Limited.
Scope of the Study
Market Segments covered in the Report:
By Application

  • Diagnosis
  • Monitoring
  • Others


By Type

  • Wireless
  • USB Camera
  • Fiber Optic Camera
  • Corded
  • Others


By End User

  • Hospitals
  • Clinics
  • Others


By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific


Companies Profiled

  • Healthy.io Ltd.
  • Ionis Pharmaceuticals, Inc.
  • Fujikura Ltd.
  • Basler AG
  • Qualcomm, Inc.
  • Hamamatsu Photonics K.K.
  • Basil Leaf Technologies
  • DynoSense Corp
  • Cloud DX Inc.
  • QuantuMDx Group Limited


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free